Skip to content
10-Q

Quarterly Report

SRx Health Solutions, Inc. SRXH

0001493152-26-023072

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · May 13, 2026 590.25M sh
Shares Diluted Q2 2026 · Mar 31, 2026 299.07M sh
Shares Diluted Q2 2026 · Mar 31, 2026 164.6M sh
Shares Diluted Q2 2026 · Mar 31, 2025 25.8M sh
Shares Diluted Q2 2026 · Mar 31, 2025 24.69M sh
Stock Repurchased Q2 2026 · Mar 31, 2026 $7K
Operating Cash Flow Q2 2026 · Mar 31, 2026 −$9.55M
Operating Cash Flow Q2 2026 · Mar 31, 2025 $72K
Long Term Debt Q2 2026 · Mar 31, 2026 $0
Long Term Debt Q2 2026 · Sep 30, 2025 $0
Short Term Investments Q2 2026 · Mar 31, 2026 $3M
Cash And Equivalents Q2 2026 · Mar 31, 2026 $20.54M
Cash And Equivalents Q2 2026 · Sep 30, 2025 $1.31M
Stockholders Equity Q2 2026 · Mar 31, 2026 $18.29M
Stockholders Equity Q2 2026 · Dec 31, 2025 $3.52M
Stockholders Equity Q2 2026 · Sep 30, 2025 $407K
Stockholders Equity Q2 2026 · Mar 31, 2025 −$58.74M
Stockholders Equity Q2 2026 · Dec 31, 2024 −$63.67M
Stockholders Equity Q2 2026 · Sep 30, 2024 −$55.12M
Current Liabilities Q2 2026 · Mar 31, 2026 $25.08M
Current Liabilities Q2 2026 · Sep 30, 2025 $3.54M
Total Liabilities Q2 2026 · Mar 31, 2026 $25.08M
Total Liabilities Q2 2026 · Sep 30, 2025 $8M
Current Assets Q2 2026 · Mar 31, 2026 $43.15M
Current Assets Q2 2026 · Sep 30, 2025 $8.13M
Total Assets Q2 2026 · Mar 31, 2026 $43.36M
Total Assets Q2 2026 · Sep 30, 2025 $8.4M
Eps Diluted Q2 2026 · Mar 31, 2026 −$0.02
Eps Diluted Q2 2026 · Mar 31, 2026 −$0.09
Eps Diluted Q2 2026 · Mar 31, 2025 −$0.39
Eps Diluted Q2 2026 · Mar 31, 2025 −$0.57
Eps Basic Q2 2026 · Mar 31, 2026 −$0.02
Eps Basic Q2 2026 · Mar 31, 2026 −$0.09
Eps Basic Q2 2026 · Mar 31, 2025 −$0.39
Eps Basic Q2 2026 · Mar 31, 2025 −$0.57
Sga Expense Q2 2026 · Mar 31, 2026 $3.09M
Sga Expense Q2 2026 · Mar 31, 2026 $7.94M
Net Income Q2 2026 · Mar 31, 2026 −$6.38M
Net Income Q2 2026 · Mar 31, 2026 −$15M
Net Income Q2 2026 · Dec 31, 2025 −$8.61M
Net Income Q2 2026 · Mar 31, 2025 −$10.15M
Net Income Q2 2026 · Mar 31, 2025 −$14.13M
Net Income Q2 2026 · Dec 31, 2024 −$3.98M
Operating Income Q2 2026 · Mar 31, 2026 −$1.82M
Operating Income Q2 2026 · Mar 31, 2026 −$5.61M
Gross Profit Q2 2026 · Mar 31, 2026 $1.28M
Gross Profit Q2 2026 · Mar 31, 2026 $2.33M
Revenue Q2 2026 · Mar 31, 2026 $3.44M
Revenue Q2 2026 · Mar 31, 2026 $6.25M